US OptionsDetailed Quotes

AKBA250117P2500

Watchlist

0.61
0.000.00%

15min DelayClose Jan 13 16:00 ET

0.00High0.00Low

Akebia Therapeutics Stock Discussion

101674396

11 hours ago

$Akebia Therapeutics (AKBA.US)$ ..Don’t sell!! hold

Jaguar8

13 hours ago

NEWS

$Akebia Therapeutics (AKBA.US)$
Akebia Therapeutics Announces Multiple Positive Business Updates
Akebia Therapeutics (NASDAQ: AKBA) announced significant business updates regarding Vafseo® (vadadustat), its treatment for anemia in chronic kidney disease (CKD) patients on dialysis. The company has secured commercial supply contracts covering nearly 100% of U.S. dialysis patients and commenced product shipments in January 2025.
Market research indicates strong physician interest, with 99% of n...

Trytosaveabit

13 hours ago

Update

$Akebia Therapeutics (AKBA.US)$ Akebia Announced Near 100% U.S. Dialysis Coverage For Vafseo, Vafseo Shipments Commence, Phase 3 Trial For Late-Stage Non-Dialysis CKD Patients Planned for Mid-2025
Benzinga· 2 mins ago
New Commercial Supply Contracts for Vafseo (vadadustat) secured, bringing availability and dialysis organization coverage to nearly 100% of patients on dialysis in U.S.
Vafseo tablets now shipping in the U.S.
Plan to start Phase 3 trial in mid-2025 to potentially expand Vafseo...